Zero human deaths from dog-mediated rabies by 2030: perspectives from quantitative and mathematical modelling.

Gates Open Research
WHO Rabies Modelling Consortium

Abstract

Dog-mediated rabies continues to kill tens of thousands of people every year in low- and middle-income countries despite being an entirely vaccine-preventable disease. WHO and partners have launched a global campaign to reach zero human deaths from dog-mediated rabies by 2030. The primary tools for reaching this target are mass dog vaccination to interrupt transmission in domestic dog populations that maintain infection, appropriate post-exposure prophylaxis (PEP) for rabies-exposed persons to prevent the fatal onset of disease, together with education to support their effective uptake. Models have been developed to assess the feasibility, impact and cost-effectiveness of these measures. From these models, we argue that the 2030 target of zero human rabies deaths is achievable, but will require concerted effort, engagement and investment. A proposed Gavi investment in human rabies vaccines has potential to drive progress towards the 2030 target; however, concomitant investment is needed to scale up mass dog vaccination or this target will be missed. Predicted economic benefits of mass dog vaccination vary according to national PEP provisioning and healthcare access. Integrated Bite Case Management can enhance surveillance and r...Continue Reading

References

Dec 17, 2010·Proceedings. Biological Sciences·Hawthorne L BeyerDaniel T Haydon
Sep 13, 2011·The Veterinary Record·Anna L OkelloSusan C Welburn
Dec 25, 2012·Comparative Immunology, Microbiology and Infectious Diseases·Sunny E TownsendKatie Hampson
Mar 19, 2013·Antiviral Research·Stephanie ShwiffAaron Anderson
Jun 27, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Marco Antonio Natal VigilatoMarcos Antonio Espinal
Aug 31, 2013·PLoS Neglected Tropical Diseases·Sunny E TownsendKatie Hampson
Mar 5, 2014·Annals of Internal Medicine·Meagan C FitzpatrickAlison P Galvani
Apr 17, 2015·PLoS Neglected Tropical Diseases·Katie HampsonUNKNOWN Global Alliance for Rabies Control Partners for Rabies Prevention
Jul 15, 2015·Bulletin of the World Health Organization·Hervé BourhyJean-Pierre Kraehenbuhl
Dec 15, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Kentaro TohmaHitoshi Oshitani
Jan 2, 2016·Acta Tropica·Louise H TaylorLouis H Nel
Oct 22, 2016·The Lancet Global Health·Bernadette Abela-RidderKatinka De Balogh
Jan 26, 2017·Frontiers in Veterinary Science·Riana A AriefFred Unger
Feb 16, 2017·Frontiers in Veterinary Science·Victor J Del Rio VilasOttorino Cosivi
Jul 19, 2017·The American Journal of Tropical Medicine and Hygiene·Eduardo A UndurragaRyan M Wallace
Oct 25, 2017·The American Journal of Tropical Medicine and Hygiene·Ryan WallaceM Millien
Dec 22, 2017·Science Translational Medicine·Jakob ZinsstagNakul Chitnis
Mar 21, 2018·PLoS Neglected Tropical Diseases·Mary Freire de CarvalhoVictor J Del Rio Vilas
Jun 8, 2018·Bulletin of the World Health Organization·K LeRouxB Abela-Ridder
Aug 31, 2018·Revue Scientifique Et Technique·A RipaniM Zrelli
Oct 22, 2018·Vaccine·Katherine L O'BrienUNKNOWN SAGE WG on Rabies
Nov 26, 2018·The Lancet Infectious Diseases·UNKNOWN WHO Rabies Modelling Consortium
Dec 12, 2018·Vaccine·Katie HampsonCaroline Trotter
Mar 30, 2019·Vaccine·Emma TaylorAnthony R Fooks
Apr 7, 2019·Vaccine·Diorbhail WentworthNai Rui Chng
Aug 6, 2019·PLoS Neglected Tropical Diseases·Julio A BenavidesKatie Hampson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.